Researchers develop affordable, rapid blood test for brain cancer
www.eurekalert.org
Researchers at the University of Notre Dame have developed a novel, automated device capable of diagnosing glioblastoma, a fast-growing and incurable brain cancer, in less than an hour. The average glioblastoma patient survives 12-18 months after diagnosis.
This is an automated archive made by the Lemmit Bot.

The original was posted on /r/science by /u/FunnyGamer97 on 2024-08-28 02:03:24+00:00.

Original Title: Researchers develop affordable, rapid blood test for brain cancer: Biochip that uses electrokinetic technology to detect biomarkers, or active Epidermal Growth Factor Receptors (EGFRs),which are overexpressed in certain cancers such as glioblastoma and found in extracellular vesicles.